High-efficiency antibody discovery achieved with multiplexed microscopy

Microscopy

Volumn 65, Issue 4, 2016, Pages 341-352

  Izquierdo, Shelley Mettler ^a   Varela, Stephanie ^a   Park, Minha ^a   Collarini, Ellen J ^a   Lu, Daniel ^a   Pramanick, Shreya ^a   Rucker, Joseph ^b   Lopalco, Lucia ^c   Etches, Rob ^a   Harriman, William ^a  

^a Crystal Bioscience Inc   (United States)

^b Integral Molecular Inc   (United States)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Antibody discovery; Chicken monoclonal antibody; DR4 DR5; GPCR; Ion channel; Single b cell cloning

Indexed keywords

ANIMALS; CELL CULTURE; CELL PROLIFERATION; CLONING; MONOCLONAL ANTIBODIES;

ANTIBODY DISCOVERY; B CELLS; CELL CLONING; CHICKEN MONOCLONAL ANTIBODY; DIAGNOSTIC APPLICATIONS; DR4 DR5; GPCR; HIGHER EFFICIENCY; ION CHANNEL; SINGLE B CELL CLONING;

CLONE CELLS;

CHEMOKINE RECEPTOR CCR5; MONOCLONAL ANTIBODY; PURINERGIC P2X3 RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL; B LYMPHOCYTE; CHICKEN; CHO CELL LINE; CRICETULUS; CYTOLOGY; DRUG DEVELOPMENT; HUMAN; HYBRIDOMA; IMMUNOLOGY; JURKAT CELL LINE; PROCEDURES; SECRETION (PROCESS); SPLEEN; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CELL LINE, TUMOR; CHICKENS; CHO CELLS; CRICETULUS; DRUG DISCOVERY; HUMANS; HYBRIDOMAS; JURKAT CELLS; RECEPTORS, CCR5; RECEPTORS, PURINERGIC P2X3; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SPLEEN;

EID: 84988407736     PISSN: 20505698     EISSN: 20505701     Source Type: Journal    
DOI: 10.1093/jmicro/dfw014     Document Type: Article

References (63)

1. Ecker D M, Jones S D, Levine H L (2015) The therapeutic monoclonal antibody market. MAbs 7: 9-14.
2. Hoogenboom H R (2005) Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 23: 1105-1116.
3. Farajnia S, Ahmadzadeh V, Tanomand A, Veisi K, Khosroshahi S A, Rahbarnia L (2014) Development trends for generation of singlechain antibody fragments. Immunopharmacol. Immunotoxicol. 36: 297-308.
4. Dufner P, Jermutus L, Minter R R (2006) Harnessing phage and ribosome display for antibody optimisation. Trends Biotechnol. 24: 523-529.
5. Boder E T, Raeeszadeh-SarmazdehM, Price J V (2012) Engineering antibodies by yeast display. Arch. Biochem. Biophys. 526: 99-106.
6. Feldhaus M J, Siegel R W (2004) Yeast display of antibody fragments:a discovery and characterization platform. J. Immunol. Methods 290: 69-80.
7. Bowers P M, Horlick R A, Kehry M R, et al. (2014) Mammalian cell display for the discovery and optimization of antibody therapeutics. Methods 65: 44-56.
8. Smith E S, Zauderer M (2014) Antibody library display on a mammalian virus vector: combining the advantages of both phage and yeast display into one technology. Curr. Drug Discov. Technol. 11: 48-55.
9. King D J, Bowers P M, KehryMR, Horlick R A (2014) Mammalian cell display and somatic hypermutation in vitro for human antibody discovery. Curr. Drug Discov. Technol. 11: 56-64.
10. Knappik A, Ge L, Honegger A, Pack P, Fischer M,Wellnhofer G, Hoess A, Wölle J, Plückthun A, Virnekäs B (2000) Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J. Mol. Biol. 296: 57-86.
11. Cobaugh C W, Almagro J C, Pogson M, Iverson B, Georgiou G (2008) Synthetic antibody libraries focused towards peptide ligands. J. Mol. Biol. 378: 622-633.
12. Brockmann E-C, Akter S, Savukoski T, et al. (2011) Synthetic single-framework antibody library integrated with rapid affinity maturation by VL shuffling. Protein Eng. Des. Sel. 24: 691-700.
13. Schwimmer L J, Huang B, Giang H, et al. (2013) Discovery of diverse and functional antibodies from large human repertoire antibody libraries. J. Immunol. Methods 391: 60-71.
14. Kügler J, Wilke S, Meier D, et al. (2015) Generation and analysis of the improved human HAL9/10 antibody phage display libraries. BMC Biotechnol. 15: 10.
15. Hoet R M, Cohen E H, Kent R B, et al. (2005) Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity. Nat. Biotechnol. 23: 344-348.
16. Sapats S I, Heine H G, Trinidad L, Gould G J, Foord A J, Doolan S G, Prowse S, Ignjatovic J (2003) Generation of chicken single chain antibody variable fragments (scFv) that differentiate and neutralize infectious bursal disease virus (IBDV). Arch. Virol. 148: 497-515.
17. Andris-Widhopf J, Rader C, Steinberger P, Fuller R, Barbas C F (2000) Methods for the generation of chicken monoclonal antibody fragments by phage display. J. Immunol.Methods 242: 159-181.
18. Sun D, Shi H, Chen J, Shi D, Zhu Q, Zhang H, Liu S, Wang Y, Qiu H, Feng L (2012) Generation of a mouse scFv library specific for porcine aminopeptidase N using the T7 phage display system. J. Virol. Methods 182: 99-103.
19. Meng W, Pan W, Zhang A J X, et al. (2013) Rapid generation of human-like neutralizing monoclonal antibodies in urgent preparedness for influenza pandemics and virulent infectious diseases. PLoS One 8: e66276.
20. Muraoka J, Ozawa T, Enomoto Y, Kiyose N, Imamura A, Arima K, Nakayama H, Ito Y (2014) Selection and characterization of human serum albumin-specific porcine scFv antibodies using a phage display library. Monoclon. Antib. Immunodiagn. Immunother. 33: 42-48.
21. Hu J, Huang X, Ling C-C, Bundle D R, Cheung N-K V (2009) Reducing epitope spread during affinity maturation of an antiganglioside GD2 antibody. J. Immunol. 183: 5748-5755.
22. Moon S A, Ki M K, Lee S, Hong M-L, Kim M, Kim S, Chung J, Rhee S G, Shim H (2011) Antibodies against non-immunizing antigens derived from a large immune scFv library. Mol. Cells 31: 509-513.
23. Hansson L-O, Flodin M, Nilsen T, Caldwell K, Fromell K, Sunde K, Larsson A (2008) Comparison between chicken and rabbit antibody based particle enhanced cystatin C reagents for immunoturbidimetry. J. Immunoassay. Immunochem. 29: 1-9.
24. Williams L M, Drew J E, Bunnett N W, Grady E, Barrett P, Abramovich D R, Morris A, Slater D (2001) Characterization of an antibody to the human melatonin mt1 receptor. J. Neuroendocrinol. 13: 94-101.
25. Lemamy G J, Roger P, Mani J C, Robert M, Rochefort H, Brouillet J P (1999) High-affinity antibodies from hen’s-egg yolks against human mannose-6-phosphate/insulin-like growth-factor-II receptor (M6P/IGFII-R): characterization and potential use in clinical cancer studies. Int. J. Cancer 80: 896-902.
26. Camenisch G, Tini M, Chilov D, Kvietikova I, Srinivas V, Caro J, Spielmann P, Wenger R H, Gassmann M (1999) General applicability of chicken egg yolk antibodies: the performance of IgY immunoglobulins raised against the hypoxia-inducible factor 1alpha. FASEB J. 13: 81-88.
27. Matsushita K, Horiuchi H, Furusawa S, Horiuchi M, Shinagawa M, Matsuda H (1998) Chicken monoclonal antibodies against synthetic bovine prion protein peptide. J. Vet. Med. Sci. 60: 777-779.
28. Murata T, Saito S, Shiozaki M, Lu R Z, Eto Y, Funaba M, Takahashi M, Torii K (1996) Anti-activin A antibody (IgY) specifically neutralizes various activin A activities. Proc. Soc. Exp. Biol. Med. 211: 100-107.
29. Gassmann M, Thommes P, Weiser T, Hubscher U (1990) Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J. 4: 2528-2532.
30. Stuart C A, Pietrzyk R A, Furlanetto R W, Green A (1988) High affinity antibody from hen’s eggs directed against the human insulin receptor and the human IGF-I receptor. Anal. Biochem. 173: 142-150.
31. Burger D, Ramus M A, Schapira M (1985) Antibodies to human plasma kallikrein from egg yolks of an immunized hen: preparation and characterization. Thromb. Res. 40: 283-288.
32. Horton J J, Holden C A, Ward P J, MacDonald D M, Sanderson A R (1985) Exploitation of phylogenetic distance in cell surface immune labeling: studies with beta 2-microglobulin. J. Invest. Dermatol. 84: 96-99.
33. Carroll S B, Stollar B D (1983) Antibodies to calf thymus RNA polymerase II from egg yolks of immunized hens. J. Biol. Chem. 258: 24-26.
34. Nishinaka S, Suzuki T, Matsuda H, Murata M (1991) A new cell line for the production of chicken monoclonal antibody by hybridoma technology. J. Immunol. Methods 139: 217-222.
35. Abdiche Y N, Harriman R, Deng X, Yeung Y A, Miles A, Morishige W, Boustany L, Zhu L, Izquierdo S M, Harriman W (2016) Assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platforms. MAbs 8: 264-277.
36. Kenney J S, Gray F, Ancel M H, Dunne J F (1995) Production of monoclonal antibodies using a secretion capture report web. Biotechnology (NY) 13: 787-790.
37. Gray F, Kenney J S, Dunne J F (1995) Secretion capture and report web: use of affinity derivatized agarose microdroplets for the selection of hybridoma cells. J. Immunol. Methods 182: 155-163.
38. Weaver J C, Williams G B, Klibanov A, Demain A L (1988) Gel microdroplets: rapid detection and enumeration of individual microorganisms by their metabolic activity. Nat. Biotechnol. 6: 1084-1089.
39. Joshi A, Garg H, Ablan S D, Freed E O (2011) Evidence of a role for soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) machinery in HIV-1 assembly and release. J. Biol. Chem. 286: 29861-29871.
40. Barassi C, Soprana E, Pastori C, Longhi R, Buratti E, Lillo F, Marenzi C, Lazzarin A, Siccardi A G, Lopalco L (2005) Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy. J. Virol. 79: 6848-6858.
41. Greene T A, Alarcon S, Thomas A, Berdougo E, Doranz B J, Breslin P A S, Rucker J B (2011) Probenecid inhibits the human bitter taste receptor TAS2R16 and suppresses bitter perception of salicin. PLoS One 6: e20123.
42. Pan G (1997) The receptor for the cytotoxic ligand TRAIL. Science 276: 111-113.
43. Sung E S, Park K J, Lee S H, Jang Y S, Park S K, Park Y H, Kwag W J, Kwon M H, Kim Y S (2009) A novel agonistic antibody to human death receptor 4 induces apoptotic cell death in various tumor cells without cytotoxicity in hepatocytes. Mol. Cancer Ther. 8: 2276-2285.
44. Lee S-H, Park D-W, Sung E-S, Park H-R, Kim J-K, Kim Y-S (2010) Humanization of an agonistic anti-death receptor 4 single chain variable fragment antibody and avidity-mediated enhancement of its cell death-inducing activity. Mol. Immunol. 47: 816-824.
45. Pukac L, Kanakaraj P, Humphreys R, et al. (2005) HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo. Br. J. Cancer 92: 1430-1441.
46. Ruiz de Almodóvar C, Ruiz-Ruiz C, Rodríguez A, Ortiz-Ferrón G, Redondo J M, López-Rivas A (2004) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site. J. Biol. Chem. 279: 4093-4101.
47. De Toni E N, Thieme S E, Herbst A, Behrens A, Stieber P, Jung A, Blum H, Göke B, Kolligs F T (2008) OPG is regulated by betacatenin and mediates resistance to TRAIL-induced apoptosis in colon cancer. Clin. Cancer Res. 14: 4713-4718.
48. Georgakis G V, Li Y, Humphreys R, Andreeff M, O’Brien S, Younes M, Carbone A, Albert V, Younes A (2005) Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL-R1 and TRAIL-R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin- and bortezomib-induced cell death. Brit. J. Haematol. 130: 501-510.
49. Ditzel H J, Rosenkilde M M, Garred P, Wang M, Koefoed K, Pedersen C, Burton D R, Schwartz T W (1998) The CCR5 receptor acts as an alloantigen in CCR5Delta32 homozygous individuals:identification of chemokineand HIV-1-blocking human antibodies. Proc. Natl. Acad. Sci. USA 95: 5241-5245.
50. Trkola A, Ketas T J, Nagashima K A, Zhao L, Cilliers T,Morris L, Moore J P, Maddon P J, Olson W C (2001) Potent, broadspectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140. J. Virol. 75: 579-588.
51. Lopalco L, Barassi C, Pastori C, Longhi R, Burastero S E, Tambussi G, Mazzotta F, Lazzarin A, Clerici M, Siccardi A G (2000) CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro. J. Immunol. 164: 3426-3433.
52. Pastori C, Diomede L, Venuti A, Fisher G, Jarvik J, Bomsel M, Sanvito F, Lopalco L (2014) Induction of HIV-blocking anti-CCR5 IgA in Peyers’s patches without histopathological alterations. J. Virol. 88: 3623-3635.
53. Pastori C, Clivio A, Diomede L, Consonni R, De Mori G M S, Longhi R, Colombo G, Lopalco L (2008) Two amino acid substitutions within the first external loop of CCR5 induce human immunodeficiency virus-blocking antibodies in mice and chickens. J. Virol. 82: 4125-4134.
54. Lopalco L (2011) Natural anti-CCR5 antibodies in HIV-infection and -exposure. J. Transl.Med. 9(Suppl 1): S4.
55. Burnstock G (2015) Physiopathological roles of P2X receptors in the central nervous system. Curr. Med. Chem. 22: 819-844.
56. Tickle S, Adams R, Brown D, Griffiths M, Lightwood D, Lawson A (2009) High-throughput screening for high affinity antibodies. J. Assoc. Lab. Automat. 14: 303-307.
57. DeKosky B J, Ippolito G C, Deschner R P, et al. (2013) Highthroughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nat. Biotechnol. 31: 166-169.
58. Baek D-S, Yong-Sung Kim P D (2015) Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif. Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2015.05.086.
59. Tsurushita N, Park M, Pakabunto K, Ong K, Avdalovic A, Fu H, Jia A, Vásquez M, Kumar S (2004) Humanization of a chicken anti-IL-12 monoclonal antibody. J. Immunol. Methods 295: 9-19.
60. Townsend S, Fennell B J, Apgar J R, et al. (2015) Augmented binary substitution: single-pass CDR germ-lining and stabilization of therapeutic antibodies. Proc. Natl. Acad. Sci. USA 112: 15354-15359.
61. Leighton P A, Schusser B, Yi H, Glanville J, Harriman W (2015) A diverse repertoire of human immunoglobulin variable genes in a chicken B cell line is generated by both gene conversion and somatic hypermutation. Front. Immunol. 6: 126.
62. Schusser B, Collarini E J, Yi H, et al. (2013) Immunoglobulin knockout chickens via efficient homologous recombination in primordial germ cells. Proc. Natl. Acad. Sci. USA 110: 20170-20175.
63. Schusser B, Yi H, Collarini E J, Izquierdo S M, Harriman W D, Etches R J, Leighton P A (2013) Harnessing gene conversion in chicken B cells to create a human antibody sequence repertoire. PLoS One 8: e80108.